Patent 11760963
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Active provider: Google · gemini-2.5-pro
No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.
Cases on file (0)
Specific litigation cases in our database that name US patent 11760963. The free-form analysis below may also discuss cases beyond this list.
No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Litigation History of US Patent 11,760,963
As of May 5, 2026, there is one known litigation case involving US patent 11,760,963. The details of the case are as follows:
Case: KetoneAid, Inc. v. Suspend Aging L.L.C. et al
- Plaintiff: KetoneAid, Inc.
- Defendants: Suspend Aging L.L.C. (doing business as ALTRD HEALTH LLC and ALTRD APE COMPANY), and Ibok Ibok (an individual).
- Jurisdiction: U.S. District Court for the District of Puerto Rico.
- Case Number: 3:25-cv-01234.
- Filing Date: April 25, 2025.
- Status: Active. On November 13, 2025, the court denied a motion to dismiss filed by defendant Ibok Ibok. On the same day, the court granted KetoneAid, Inc.'s motion for an entry of default against defendant Suspend Aging L.L.C. The court also enjoined Suspend Aging L.L.C. from using the active ingredient as protected in Claim 1 of the '963 patent. A hearing to determine monetary damages is to be scheduled.
Generated 5/5/2026, 12:02:02 AM